Investigators presented a novel strategy using a genetic “AND” gate that integrates chemically-induced proximity and tumor-activated prodrug approaches to generate TME-iCAR-T cell that are capable of sensing multiple tumor-specific characteristics to precisely execute therapeutic functions within the TME.
[Molecular Therapy]